Transaction · 0001051578-26-000010

Pyott David E I

PYOTT DAVID E I, DIR, reported a transaction classified as exercise at Tarsus Pharmaceuticals, Inc. involving 201.000000 shares. Reported holdings after the transaction were 9575.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MDIR
TARSTarsus Pharmaceuticals, Inc.
Trade date
Sep 15, 2026
Filing date
Sep 17, 2026
View on SEC Insider profile
Disclosed valueUnknownShares × reported price
Shares traded201Price unknown
Holdings after9.57kIndirect · By the David E.I. Pyott Trust
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

TARS price since this filing

Daily closing prices, with the filing date and available return windows
TARS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -12.4%1w ago -8.9%1d ago +1.2%
Returns since7d -3.9%30d -13.9%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001051578-26-000010
Common Stock
Transaction date
Sep 15, 2026
Filed Sep 17, 2026, 08:47 PM · 2d delay
Shares
201 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
9,575 sh
Indirect · By the David E.I. Pyott Trust
Filing-only score

-4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

  2. F2

    Includes 1,383 shares previously owned directly that were transferred to the reporting person's trust on May 14, 2026. There was no change in the reporting person's pecuniary interest in the shares.

  3. F3

    Each RSU represents a contingent right to receive one share of the Company's common stock.

  4. F4

    RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/…

Original filing · 0001051578-26-000010
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TARS